Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajiv Radhakrishnan

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Psychological Medicine|October 5, 2018
Interaction between environmental and familial affective risk impacts psychosis admixture in states of affective dysregulationRajiv Radhakrishnan, Sinan Guloksuz, Margreet Ten Have, et al.
Molecular Psychiatry|September 25, 2020
Preliminary in vivo evidence of lower hippocampal synaptic density in cannabis use disorderDeepak Cyril D'Souza, Rajiv Radhakrishnan, Mika Naganawa, et al.
Psychiatry Research. Neuroimaging|November 25, 2019
In vivo 5-HT<sub>6</sub> and 5-HT<sub>2A</sub> receptor availability in antipsychotic treated schizophrenia patients vs. unmedicated healthy humans measured with [<sup>11</sup>C]GSK215083 PETRajiv Radhakrishnan, David Matuskey, Nabeel Nabulsi, et al.
Molecular Psychiatry|June 17, 2021
In vivo evidence of lower synaptic vesicle density in schizophreniaRajiv Radhakrishnan, Patrick D Skosnik, Mohini Ranganathan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 25, 2012
Feasibility, safety, and efficacy of the combination of D-serine and computerized cognitive retraining in schizophrenia: an international collaborative pilot studyDeepak C D'Souza, Rajiv Radhakrishnan, Edward Perry, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 24, 2017
Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal informationMohini Ranganathan, Rajiv Radhakrishnan, Peter H Addy, et al.
Psychological Medicine|September 12, 2022
Bidirectional relationships between cannabis use, anxiety and depressive symptoms in the mediation of the association with psychotic experience: further support for an affective pathway to psychosisRajiv Radhakrishnan, Lotta-Katrin Pries, Gamze Erzin, et al.
Schizophrenia Bulletin|April 28, 2018
Evidence That Environmental and Familial Risks for Psychosis Additively Impact a Multidimensional Subthreshold Psychosis SyndromeLotta-Katrin Pries, Sinan Guloksuz, Margreet Ten Have, et al.
Biological Psychiatry|October 4, 2015
Reduced Brain Cannabinoid Receptor Availability in SchizophreniaMohini Ranganathan, Jose Cortes-Briones, Rajiv Radhakrishnan, et al.
Psychological Medicine|August 31, 2018
Reasoning bias, working memory performance and a transdiagnostic phenotype of affective disturbances and psychotic experiences in the general populationUlrich Reininghaus, Christian Rauschenberg, Margreet Ten Have, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Psychological Medicine|October 5, 2018
Interaction between environmental and familial affective risk impacts psychosis admixture in states of affective dysregulationRajiv Radhakrishnan, Sinan Guloksuz, Margreet Ten Have, et al.
Molecular Psychiatry|September 25, 2020
Preliminary in vivo evidence of lower hippocampal synaptic density in cannabis use disorderDeepak Cyril D'Souza, Rajiv Radhakrishnan, Mika Naganawa, et al.
Psychiatry Research. Neuroimaging|November 25, 2019
In vivo 5-HT<sub>6</sub> and 5-HT<sub>2A</sub> receptor availability in antipsychotic treated schizophrenia patients vs. unmedicated healthy humans measured with [<sup>11</sup>C]GSK215083 PETRajiv Radhakrishnan, David Matuskey, Nabeel Nabulsi, et al.
Molecular Psychiatry|June 17, 2021
In vivo evidence of lower synaptic vesicle density in schizophreniaRajiv Radhakrishnan, Patrick D Skosnik, Mohini Ranganathan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 25, 2012
Feasibility, safety, and efficacy of the combination of D-serine and computerized cognitive retraining in schizophrenia: an international collaborative pilot studyDeepak C D'Souza, Rajiv Radhakrishnan, Edward Perry, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 24, 2017
Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal informationMohini Ranganathan, Rajiv Radhakrishnan, Peter H Addy, et al.
Psychological Medicine|September 12, 2022
Bidirectional relationships between cannabis use, anxiety and depressive symptoms in the mediation of the association with psychotic experience: further support for an affective pathway to psychosisRajiv Radhakrishnan, Lotta-Katrin Pries, Gamze Erzin, et al.
Schizophrenia Bulletin|April 28, 2018
Evidence That Environmental and Familial Risks for Psychosis Additively Impact a Multidimensional Subthreshold Psychosis SyndromeLotta-Katrin Pries, Sinan Guloksuz, Margreet Ten Have, et al.
Biological Psychiatry|October 4, 2015
Reduced Brain Cannabinoid Receptor Availability in SchizophreniaMohini Ranganathan, Jose Cortes-Briones, Rajiv Radhakrishnan, et al.
Psychological Medicine|August 31, 2018
Reasoning bias, working memory performance and a transdiagnostic phenotype of affective disturbances and psychotic experiences in the general populationUlrich Reininghaus, Christian Rauschenberg, Margreet Ten Have, et al.
Pageof 8